Primary care physicians’ perspectives on adults with diabetes and the recommended hepatitis B vaccine: A qualitative study
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0312168 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift PLOS ONE, 2024. Verfasst von Douwné L Müller und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family and Community Medicine, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States of America. Hauptthemen laut MEDLINE: Physicians, Primary Care, Hepatitis B Vaccines, Hepatitis B, Vaccination. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Craig H. Neilsen Foundation.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
People with diabetes are at an increased risk of contracting the hepatitis B virus (HBV). However, hepatitis B (HepB) vaccination rates among adults with diabetes are low. Factors influencing HepB vaccination have not been adequately explored.
Aims
The study aims to identify and understand the barriers adults with diabetes have in receiving the recommended HepB vaccine from the physicians’ perspective.
Methods
This study used semi-structured interviews to ascertain the perspective of 11 primary care physicians (PCPs) in a large academic medical group about HepB vaccination among their patients with Type 1 and 2 diabetes. Thematic analysis yielded descriptions of barriers and strategies that could potentially impact HepB vaccination among adults with diabetes.
Results
Physician responses related to four themes: (1) Conflicting perceptions about HBV risk and the CDC recommendation for adults with diabetes; (2) PCPs don’t perceive HepB vaccination as important as other adult vaccines and prioritize vaccination based on risk exposure; (3) PCPs’ perceived barriers to HepB vaccination among adults with diabetes; and (4) Physician recommended strategies to increase HepB vaccination among adults with diabetes.
Conclusion
Our findings indicate that physicians are generally aware of the existence of the CDC guidelines, but not all physicians recommend the HepB vaccine to adults with diabetes. This is because of a wide variation in treatment concerning glucose monitoring or insulin injection due to varying opinions about actual risk. We also identified barriers adults with diabetes have in receiving the HepB vaccine and strategies to increase HepB vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Family and Community Medicine, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States of America.
- Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States of America.
- Department of Medicine, Humanities, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States of America.
- Penn State Cancer Institute, Hershey, Pennsylvania, United States of America.
ORCID-Profile: Douwné L Müller, Jessica Yingst
Förderung
- Craig H. Neilsen Foundation
Zitieren
APA
Müller, D. L., Stuckey, H., Flores, E. S., Wang, L., Godfrey, T., Calo, W. A., & Yingst, J. (2024). Primary care physicians’ perspectives on adults with diabetes and the recommended hepatitis B vaccine: A qualitative study. PLOS ONE. https://doi.org/10.1371/journal.pone.0312168
Vancouver
Müller DL, Stuckey H, Flores ES, Wang L, Godfrey T, Calo WA, et al. Primary care physicians’ perspectives on adults with diabetes and the recommended hepatitis B vaccine: A qualitative study. PLOS ONE. 2024. doi:10.1371/journal.pone.0312168
BibTeX
@article{Mller2024,
author = {Müller, Douwné L and Stuckey, Heather and Flores, Eileen S and Wang, Li and Godfrey, Thomas and Calo, William A and Yingst, Jessica},
title = {Primary care physicians’ perspectives on adults with diabetes and the recommended hepatitis B vaccine: A qualitative study},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0312168}
}
EUVIMED